Actively Recruiting
Chinese DENOVO PD Registry
Led by Xiangya Hospital of Central South University · Updated on 2023-03-14
300
Participants Needed
1
Research Sites
521 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The main objective of this longitudinal, multi-center study is to explore the clinical characteristics of PD and confirm biomarkers for PD evolution or progression.
CONDITIONS
Official Title
Chinese DENOVO PD Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with Parkinson's disease by MDS Clinical Diagnostic Criteria
- Disease duration of 2 years or less at baseline
- Hoehn-Yahr stage 2 or less at baseline
- Age between 30 and 75 years
- No prior antiparkinsonian treatment
- Able to provide written informed consent
You will not qualify if you...
- Diagnosed with parkinsonism-syndrome
- Treated with antiparkinsonian drugs at baseline
- Presence of cognitive impairment
- Unable to provide written informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Xiangya Hospital of Central South University
Changsha, Hunan, China, 410008
Actively Recruiting
Research Team
J
Jifeng Guo, Ph.D
CONTACT
B
Beisha Tang, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here